Summary
AstraZeneca has announced a major investment of over £100 million, with Cheshire and Warrington Combined Authority describing the pharmaceutical giant as a 'world-leader' in the sector. The substantial investment commitment was highlighted by the Combined Authority's chief executive, underlining the significant economic impact for the North West region. As reported by Prolific North, this development represents a major boost for the area's life sciences sector and demonstrates continued confidence in the region's pharmaceutical capabilities. The investment is expected to strengthen Greater Manchester's position within the broader North West life sciences ecosystem.
Read the full story at Prolific North
This is a summary written for the Manchester Business Services register. The full article belongs to Prolific North — read it at source.
Organisations mentioned
- AstraZeneca
- Cheshire and Warrington Combined Authority
- Prolific North
Common questions
- What is this article about?
- AstraZeneca commits over £100m investment with Cheshire and Warrington Combined Authority chief hailing the pharmaceutical company as a 'world-leader', boosting the Greater Manchester region's life sciences sector.
- When was this published?
- This article was published on 3 May 2026.
- Who published this article?
- This article was published by Prolific North.
- Which organisations does this article mention?
- This article mentions AstraZeneca, Cheshire and Warrington Combined Authority, Prolific North.